Drug Profile
Research programme: superoxide dismutase mimics - SIDR
Alternative Names: Research programme: superoxide dismutase mimics - Strathclyde Institute for Drug Research; Superoxide dismutase mimics research programme - SIDR; Superoxide dismutase mimics research programme - Strathclyde Institute for Drug ResearchLatest Information Update: 04 Aug 2004
Price :
$50
*
At a glance
- Originator Strathclyde Institute for Drug Research
- Class
- Mechanism of Action Free radical scavengers; Superoxide dismutase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 04 Aug 2004 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
- 20 Jul 1999 Available for licensing (http://www.sidr.org)
- 20 Jul 1999 Preclinical development for Cancer in United Kingdom (Unknown route)